MedPath

Association Between Testosterone Levels and COPD Severity

Conditions
Chronic Obstructive Pulmonary Disease
Hypogonadism
Registration Number
NCT02824809
Lead Sponsor
Hospital Italiano de Buenos Aires
Brief Summary

The Aims of the study are estimate the association between the severity of COPD and free testosterone level and the prevalence of hypogonadism in adult men with stable COPD

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
150
Inclusion Criteria
  • Adults Men ≥ 45 years
  • COPD defined according to clinical diagnosis and spirometry American thoracic society ( ATS) criteria
  • Stable COPD without recent acute exacerbation (less than 2 weeks)
Exclusion Criteria
  • Refusal to participate or informed consent process
  • Those who are under treatment with testosterone replacement or anti-androgens
  • Comorbidities: Cirrhosis, Alcoholism, cryptorchidism, panhypopituitarism, Pituitary adenoma.
  • Orchiectomy
  • Systemic glucocorticoids (equivalent dose ≥ 4 mg of prednisone in the last 3 weeks).
  • Relative and absolute contraindications for spirometry.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Free testosterone LevelOne day
Secondary Outcome Measures
NameTimeMethod
Prevalence of HypogonadismOne day

Trial Locations

Locations (1)

Hospital Italiano de Buenos Aires

🇦🇷

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

© Copyright 2025. All Rights Reserved by MedPath